RGEN Exercise Disclosure
Loeillot Olivier · SEC Form 4 · Filed Oct 6, 2026
Exercise
Calculated transaction value
$0
Loeillot Olivier Chief Executive Officer
RGEN
Repligen Corp
RGEN
Transaction date
Oct 5, 2026
Public filing date
Oct 6, 2026
Filing lag
Filed 1 day later
RGEN daily price context
Close on/before transaction
$189.5
Oct 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 4,202 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-065238
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.69M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Repligen Corp RGEN | Sale | Oct 5, 2026 | $238.27K |
| Repligen Corp RGEN | Exercise | Oct 5, 2026 | $651.14K |
| Repligen Corp RGEN Current | Exercise | Oct 5, 2026 | $0 |
| Repligen Corp RGEN | Sale | Oct 5, 2026 | $798.38K |